![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_762429a93cd073a0fe051daeaab480c5.svg) | Verlukast | IC50 | 400.0 [1], 3300.0 [2], 5220.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_762429a93cd073a0fe051daeaab480c5.svg) | Verlukast | Ki | 600.0 [1], 134700.0 [2], 139600.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_beb7f72e73f61c5a9e1bf58b6572d39a.svg) | Cyclosporin A | IC50 | 2700.0 [1], 2810.0 [2], 2970.0 [3], 3530.0 [4], 4780.0 [5] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_beb7f72e73f61c5a9e1bf58b6572d39a.svg) | Cyclosporin A | Ki | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_01814a6086009d7440d5f435a324c600.svg) | Verapamil | IC50 | 3500.0 [1], 6800.0 [2], 9660.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_01814a6086009d7440d5f435a324c600.svg) | Verapamil | Ki | 13200.0 [1], 13400.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_1ee4092ba59e9152a5257732c733158d.svg) | 4-(2-Phenylethylamino)-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | IC50 | 250.0 [1], 4980.0 [2], 6300.0 [3], 8370.0 [4] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_ce92b190d75ea05d91d907a663a8eb48.svg) | Daunorubicin | IC50 | 8000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_ce92b190d75ea05d91d907a663a8eb48.svg) | Daunorubicin | Ki | 70.0 [1], 950.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_926035c06d9d341c1f456b3b189f3e17.svg) | Mitoxantrone | IC50 | 1.5 [1], 1.9 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_e25c9d2f82c5eda0b783aad009b4d224.svg) | Myricetin | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_e25c9d2f82c5eda0b783aad009b4d224.svg) | Myricetin | Ki | 2400.0 [1], 13300.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_a1391d76f6ee6804bcfd81b3f264ad08.svg) | 4-[[4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-6,8-dinitro-5H-pyrimido[5,4-b]indol-2-yl]methyl]morpholine | IC50 | 19.0 [1], 118.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_3336874b304bb167a7e6d63f99461b20.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-5H-pyrimido[5,4-b]indole-9-carboxamide | IC50 | 65.0 [1], 183.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_26f117018bf6f088f8a5861cd7c9787c.svg) | 4-(4-Phenethyl-piperazin-1-yl)-6,7,8,9-tetrahydro-pyrimido[4,5-b]indolizine-10-carbonitrile | IC50 | 197.0 [1], 370.0 [2], 690.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_15bcdc509109f2142fd979cbc1e2c5d9.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-N-pyridin-4-yl-5H-pyrimido[5,4-b]indole-9-carboxamide | IC50 | 250.0 [1], 650.0 [2], 708.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_b3ad24687858a56156c8c48728f43f7f.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-5-(pyridin-4-ylmethyl)pyrimido[5,4-b]indole-9-carboxamide | IC50 | 20.0 [1], 250.0 [2], 270.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_74259b4c9d7cd4d3e3a188d0ecd46c02.svg) | 6-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-8-methyl-3,5,8,13-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene | IC50 | 94.0 [1], 250.0 [2], 270.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_124836a6be3f96fa6a0c2dbf8464b624.svg) | Ethyl 2-[4-[4-[2-(3,4-difluorophenyl)ethyl]piperazin-1-yl]-8-nitropyrimido[5,4-b]indol-5-yl]acetate | IC50 | 78.0 [1], 138.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_317d7b956854144f9861af3abd3323b1.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-9-methyl-5H-pyrimido[5,4-b]indole | IC50 | 250.0 [1], 632.0 [2], 1235.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_1d856d77f79200b03d3c5662a317a83f.svg) | 6-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-8,13-dimethyl-3,5,8,12-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene | IC50 | 21.0 [1], 33.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_70c65d7ad0bf73456bf4eec69bef4303.svg) | 13-Chloro-6-[4-[2-(3,4-difluorophenyl)ethyl]piperazin-1-yl]-8-methyl-3,5,8,12-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene | IC50 | 41.0 [1], 130.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_0800b06692a99366a2da7defd3ec5408.svg) | 8-Benzyl-6-[4-[2-(3,4-difluorophenyl)ethyl]piperazin-1-yl]-3,5,8,12-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene | IC50 | 48.0 [1], 250.0 [2], 545.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_f2f8460970ddfdada256d3425dfd1f56.svg) | 6-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-8-methyl-N-(pyridin-2-ylmethyl)-3,5,8,12-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-13-amine | IC50 | 15.0 [1], 106.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_c0f583c5aeb9b334f3dc18acb6536d9b.svg) | 4-[[13-Chloro-6-[4-[2-(3,4-difluorophenyl)ethyl]piperazin-1-yl]-8-methyl-3,5,8,12-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl]methyl]morpholine | IC50 | 17.0 [1], 90.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_423e2b3316cce69ab663ad868eb7812f.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-5H-pyrimido[5,4-b]indol-9-amine | IC50 | 250.0 [1], 708.0 [2], 1900.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_943ca19bfced2eda595be2b8c06a8e9e.svg) | Methyl 4-[4-[2-(3,4-difluorophenyl)ethyl]piperazin-1-yl]-5H-pyrimido[5,4-b]indole-8-carboxylate | IC50 | 59.0 [1], 113.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_85e22389df538bbdb40917344d61aef3.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-9-nitro-5-(pyridin-4-ylmethyl)pyrimido[5,4-b]indole | IC50 | 13.7 [1], 80.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_89333011f4530260d3d5395943457fa7.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-9-nitro-5-(2-phenylethyl)pyrimido[5,4-b]indole | IC50 | 40.9 [1], 222.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_8c5a570c01cd232436381551612d8a0c.svg) | 6-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-N,8-dimethyl-3,5,8,12-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-13-amine | IC50 | 28.0 [1], 115.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_28306afa5a398a68f0db3ef930bae4c4.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-9-nitro-5H-pyrimido[5,4-b]indole | IC50 | 59.0 [1], 183.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_7db623e82c1afa03778d4a8b7e772a39.svg) | 6-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-8-methyl-3,5,8,10-tetrazatricyclo[7.4.0.02,7]trideca-1(13),2(7),3,5,9,11-hexaene-13-carboxamide | IC50 | 12.0 [1], 110.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_7c9e04a180d93aaaca7efd0e5f18d06e.svg) | 6-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-N,N,8-trimethyl-3,5,8,12-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-13-amine | IC50 | 12.0 [1], 166.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_dc763c0e61af6cab3dae654efc10e8d1.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-5-methyl-9-nitropyrimido[5,4-b]indole | IC50 | 147.0 [1], 231.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_c08b6b71c88dd46835b4a73d8f7f247e.svg) | 6-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-8-methyl-4-(morpholin-4-ylmethyl)-3,5,8,10-tetrazatricyclo[7.4.0.02,7]trideca-1(13),2(7),3,5,9,11-hexaene-13-carboxamide | IC50 | 10.0 [1], 97.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_282763a32698eb83ef47c1b240234880.svg) | 6-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-8-methyl-3,5,8,12-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene | IC50 | 24.0 [1], 44.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_c229c4683068304134ee6275996cd0df.svg) | 6-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-8-methyl-3,5,8,10-tetrazatricyclo[7.4.0.02,7]trideca-1(13),2(7),3,5,9,11-hexaene-13-carbonitrile | IC50 | 45.0 [1], 250.0 [2], 355.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_0217adacc526ba5a43d05802277b4be0.svg) | 9-Chloro-4-[4-[2-(3,4-difluorophenyl)ethyl]piperazin-1-yl]-5H-pyrimido[5,4-b]indole | IC50 | 167.0 [1], 250.0 [2], 367.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_1972f5385fa5e42495b24a2d884b5569.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-5H-pyrimido[5,4-b]indole-9-carbonitrile | IC50 | 169.0 [1], 250.0 [2], 277.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_e75696564bb701bd5eb81a7c5b2191f8.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-8-methoxy-5H-pyrimido[5,4-b]indole | IC50 | 250.0 [1], 608.0 [2], 820.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_2041b64897c0b794566230c5d54f26a9.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-5-methyl-2-(morpholin-4-ylmethyl)pyrimido[5,4-b]indole-9-carboxamide | IC50 | 29.0 [1], 230.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_31e2eef409062f8263f7e11fa9d97251.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-8-methoxy-9-nitro-5H-pyrimido[5,4-b]indole | IC50 | 78.0 [1], 156.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_92bfde98682464982855044c44553b58.svg) | 11-Chloro-6-[4-[2-(3,4-difluorophenyl)ethyl]piperazin-1-yl]-8-methyl-3,5,8,12-tetrazatricyclo[7.4.0.02,7]trideca-1(13),2(7),3,5,9,11-hexaene | IC50 | 87.0 [1], 250.0 [2], 1200.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_b554d58665ce582da559ed62be7ca23c.svg) | 6-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-13-methoxy-8-methyl-3,5,8,12-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene | IC50 | 63.0 [1], 172.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_5812cf326458841b0c13fac5940e0983.svg) | 13-Chloro-6-[4-[2-(3,4-difluorophenyl)ethyl]piperazin-1-yl]-4-(methoxymethyl)-8-methyl-3,5,8,12-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene | IC50 | 13.0 [1], 244.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_8f03dc3003a5aa24be13a29d031049de.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-9-nitro-5-(pyridin-3-ylmethyl)pyrimido[5,4-b]indole | IC50 | 26.5 [1], 250.0 [2], 621.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_729882528be8705b8d006812fc5ad3b5.svg) | 4-[6-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-8-methyl-3,5,8,12-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-13-yl]morpholine | IC50 | 10.0 [1], 71.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_89dc2ac2ad93ff8d1479d5b8b3832688.svg) | 4-[[4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-8-nitro-5H-pyrimido[5,4-b]indol-2-yl]methyl]morpholine | IC50 | 107.0 [1], 250.0 [2], 672.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_7c45ccea9bf4d06950a7f5ccbd3e8ee7.svg) | 6-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-8-methyl-13-propan-2-yloxy-3,5,8,12-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene | IC50 | 27.0 [1], 250.0 [2], 265.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_42a40a064147e39d8a62bc5dd92d1df4.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-8-pyrrolidin-1-ylsulfonyl-5H-pyrimido[5,4-b]indole | IC50 | 235.0 [1], 250.0 [2], 542.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_8f9540899a901b365f2923ba8e297ea1.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-8-nitro-5H-pyrimido[5,4-b]indole | IC50 | 51.0 [1], 133.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_7b0f91f37174bdaf79bfcb1f3d40ef21.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-5-methylpyrimido[5,4-b]indole-9-carboxamide | IC50 | 24.0 [1], 62.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_ef61fa49423965b00cafb173f3e07a26.svg) | Indomethacin | IC50 | 12000.0 [1], 12600.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_2016e1fb48c552930d228a3e7f6e1433.svg) | Quercetin | Ki | 2400.0 [1], 8100.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_a2cf57bd6f8c46fcf64697efa5bb4d5b.svg) | Apigenin | Ki | 2400.0 [1], 4900.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_a8d143b77bac15fc3de70b49c42cacc7.svg) | Kaempferol | Ki | 2400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_e3ca5e157e9aaa9db0662417536b4184.svg) | Naringenin | Ki | 2400.0 [1], 20800.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_9aaa71f5c6e9623ba848e1c72bab5cd8.svg) | Benzbromarone | IC50 | 4000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_9aaa71f5c6e9623ba848e1c72bab5cd8.svg) | Benzbromarone | Ki | 190.0 [1] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_d09747bfee72fc8035466377f680eadc.svg) | MK-571 sodium | IC50 | 7570.0 [1], 30000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_f58f402fa016af798398fbd8048f40cd.svg) | Ivermectine | IC50 | 3800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_f58f402fa016af798398fbd8048f40cd.svg) | Ivermectine | Ki | 500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_b1defc2de62c1df9aff680bcb93af1f1.svg) | (5S,6R,7E,9E,11Z,14Z)-6-[(2S)-2-[[(4S)-4-Amino-4-carboxybutanoyl]amino]-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid | Ki | 300.0 [1], 530.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_9eadcb9e4bac6774ac7bcf86aeb780ef.svg) | 6-Methyl-2-[4-[2-[2-[2-[2-[2-[4-(6-methyl-4-oxochromen-2-yl)phenoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]phenyl]chromen-4-one | Ki | 190.0 [1], 200.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_2e9fa56696d48714217ba91c22057937.svg) | Unii-73CI11LH7F | IC50 | 800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_4a4f864f42b4979e8593b49c9eac6548.svg) | N-(3,4-Dimethoxyphenyl)-2-phenylquinazolin-4-amine | IC50 | 11180.0 [1] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_27d4d69f83884d1283acd3b265f8dc4f.svg) | Phenyl-[4-[4-(2-phenylethyl)piperazin-1-yl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizin-10-yl]methanone | IC50 | 250.0 [1], 1370.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_64441f37f9271761842bc2b34c25edb8.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-N-pyridin-3-yl-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carboxamide | IC50 | 76.0 [1], 250.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_e5651551a76108bdffdea2adaaa799ac.svg) | 4-(4-Phenacylpiperazin-1-yl)-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | IC50 | 250.0 [1], 1850.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_26cd4354da5c9ef7d1c5d0c1edc00127.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | IC50 | 229.0 [1], 250.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_4b0592520d015c2b9eede8862bf9ccbf.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-2-pyridin-3-yl-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | IC50 | 218.0 [1], 250.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_b83a59190a8eec1a6904056a2212487b.svg) | 4-[4-[2-(3-Nitrophenyl)ethyl]piperazin-1-yl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | IC50 | 250.0 [1], 410.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_0b6190ed81ac8f56be40c87491ed13c9.svg) | 4-[4-(3-Phenylpropyl)piperazin-1-yl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | IC50 | 250.0 [1], 7350.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_9da9bf1e4f4c8e09f59b97a6bdff5f2e.svg) | 4-[4-[2-(4-Nitrophenyl)ethyl]piperazin-1-yl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | IC50 | 250.0 [1], 523.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_1c56a859942d553155c9037f16d35724.svg) | 4-[4-[2-(4-Methoxyphenyl)ethyl]piperazin-1-yl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | IC50 | 250.0 [1], 50000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_f52c8f19b396ce8e3b8139ffcf4686ce.svg) | 2-Phenyl-4-[4-(2-phenylethyl)piperazin-1-yl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | IC50 | 250.0 [1], 715.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_343e9d1033d61eebe22ab585572f6ecb.svg) | 4,5-Dimethyl-2-[4-[4-(2-phenylethyl)piperazin-1-yl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizin-10-yl]-1,3-thiazole | IC50 | 250.0 [1], 533.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_9cd316c3f14426bba1e79011ddf1e3cd.svg) | 2-Iodo-4-[4-(2-phenylethyl)piperazin-1-yl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | IC50 | 250.0 [1], 887.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_da1aacbd4e938e5d4ef6e7f075f0bce6.svg) | 4-(4-Benzylsulfonylpiperazin-1-yl)-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | IC50 | 250.0 [1], 6650.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_2605bbb5050ba52e4bc595af485620c6.svg) | 4-[4-[2-(3-Chlorophenyl)ethyl]piperazin-1-yl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | IC50 | 250.0 [1], 920.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_e129b72742abd7a75f09e6a0523830e9.svg) | Methyl 4-[4-(2-phenylethyl)piperazin-1-yl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carboxylate | IC50 | 250.0 [1], 910.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_9c72cee1b646c35c5ab82dff60d01984.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carboxamide | IC50 | 138.0 [1], 250.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_cbb4c6ebd429d095f03934e1e9a8ab8e.svg) | N-[4-[10-Cyano-4-[4-(2-phenylethyl)piperazin-1-yl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizin-2-yl]phenyl]acetamide | IC50 | 250.0 [1], 570.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_f2d8174c11a44ad05287f1d4d9b828d6.svg) | 4-[2-(3,4-Dihydro-1H-isoquinolin-2-yl)ethylamino]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | IC50 | 250.0 [1], 6350.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_b58c955e712cc129dc54233149743def.svg) | 4-[4-[2-(4-Chlorophenyl)ethyl]piperazin-1-yl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | IC50 | 250.0 [1], 399.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_904b747cc8ca4ae4d64f9d87efd2a7f1.svg) | 4-(Methyl-phenethyl-amino)-6,7,8,9-tetrahydro-pyrimido[4,5-b]indolizine-10-carbonitrile | IC50 | 250.0 [1], 9000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_ad694e2647a90983833f1c69b3ed3910.svg) | 1-[4-[4-(2-Phenylethyl)piperazin-1-yl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizin-10-yl]propan-1-one | IC50 | 250.0 [1], 2800.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_7bdc1bb02a934f997f940249752c0bb8.svg) | 4-[4-[2-(3-Methoxyphenyl)ethyl]piperazin-1-yl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | IC50 | 250.0 [1], 2300.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_9db5122cadb441f0ac92acb913348a35.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-5H-pyrimido[5,4-b]indole-8-carboxamide | IC50 | 250.0 [1], 3440.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_844f8cb72a7cfee3253404d381013a89.svg) | N-[4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-5H-pyrimido[5,4-b]indol-8-yl]acetamide | IC50 | 250.0 [1], 2710.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_d84947352aae02aa88cda64541225dab.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-7-methoxy-5H-pyrimido[5,4-b]indole | IC50 | 250.0 [1], 3150.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_06eda565885177fb598f923fc5bc2f48.svg) | N-(10-Cyano-6,7,8,9-tetrahydropyrimido[4,5-b]indolizin-4-yl)-1-phenylmethanesulfonamide | IC50 | 250.0 [1], 20900.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_b772f9ca44512b51dcbcc41e35fcddf7.svg) | 4-[4-(2-Phenylethyl)piperazin-1-yl]-10-pyrimidin-2-yl-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine | IC50 | 250.0 [1], 675.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_f84eeb0774eb50d93a7c5161ddad19f4.svg) | 4-[4-[2-(2-Nitrophenyl)ethyl]piperazin-1-yl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | IC50 | 250.0 [1], 1415.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_85b3e0e1651a931064dd02cf2a9e2382.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-N-ethyl-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carboxamide | IC50 | 120.0 [1], 250.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_02e639bb7b0de7e26ff52912e88d5ea2.svg) | 4-[4-[2-(2-Chlorophenyl)ethyl]piperazin-1-yl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | IC50 | 250.0 [1], 955.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_c669b9f58bbd63b150986ad672fd8ed6.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-2-(2-methylphenyl)-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | IC50 | 250.0 [1], 620.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_7f5bf1f1b6073a46c4957879482b0721.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-N-[(2,3-dimethoxyphenyl)methyl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carboxamide | IC50 | 43.0 [1], 250.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_f213ff255b164bafa04edca6b3f85a64.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-7-methoxy-6-nitro-5H-pyrimido[5,4-b]indole | IC50 | 250.0 [1], 3450.0 [2] |
![](https://images.aatbio.com/dataset/ic50/multidrug-resistance-associated-protein-1_6961921917c3eddbd1cbc6871f00ccaa.svg) | 4-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-2-pyridin-4-yl-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | IC50 | 105.0 [1], 250.0 [2] |